These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9853602)

  • 1. Trimmed down Chiron pitches cancer genomics.
    Hodgson J
    Nat Biotechnol; 1998 Dec; 16(13):1308. PubMed ID: 9853602
    [No Abstract]   [Full Text] [Related]  

  • 2. King of the pill. Pfizer is the biggest drug company ever. Can it become the best?
    Simons J
    Fortune; 2003 Apr; 147(7):94-6, 100, 102. PubMed ID: 12698860
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug industry in India is threatened by free trade agreement].
    Jeppsson A
    Lakartidningen; 2009 Oct 7-13; 106(41):2589. PubMed ID: 19927922
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription drug pushers. Patents and ads are the big reasons pills are priced like perfume and caviar.
    Sherrid P
    US News World Rep; 2000 Oct; 129(17):40-2. PubMed ID: 11184929
    [No Abstract]   [Full Text] [Related]  

  • 5. More fizz at Pfizer?
    Nature; 2006 Aug; 442(7104):734. PubMed ID: 16915258
    [No Abstract]   [Full Text] [Related]  

  • 6. Indian biogenerics industry emerges.
    Jayaraman KS
    Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
    [No Abstract]   [Full Text] [Related]  

  • 7. Compulsory licenses and access to HIV/AIDS drugs.
    Zuniga JM; Wilder R
    IAPAC Mon; 2001 Dec; 7(12):328-32. PubMed ID: 11799944
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical innovation and patent gridlock.
    James JS
    AIDS Treat News; 2005 May; (412):6-8. PubMed ID: 16050004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The London Agreement and the future of parallel imports.
    Muir J
    Nat Biotechnol; 2008 Aug; 26(8):877-9. PubMed ID: 18688237
    [No Abstract]   [Full Text] [Related]  

  • 10. Market watch: Sales of biologics to show robust growth through to 2013.
    Goodman M
    Nat Rev Drug Discov; 2009 Nov; 8(11):837. PubMed ID: 19876035
    [No Abstract]   [Full Text] [Related]  

  • 11. [What drug companies actually do].
    Tonby K
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1806. PubMed ID: 17599137
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotech battle royale. Two firms fight over billion-dollar drug.
    Sherrid P
    US News World Rep; 2000 Mar; 128(11):52. PubMed ID: 10848209
    [No Abstract]   [Full Text] [Related]  

  • 13. Sales from licensed and acquired products to increase by 2013.
    Goodman M
    Nat Rev Drug Discov; 2009 Jun; 8(6):443. PubMed ID: 19483704
    [No Abstract]   [Full Text] [Related]  

  • 14. What shoulder and what art.
    Nat Rev Drug Discov; 2005 Dec; 4(12):943. PubMed ID: 16370069
    [No Abstract]   [Full Text] [Related]  

  • 15. Pfizer breaks from merger mentality as others chase leads.
    Weaver J
    Nat Med; 2011 Jul; 17(7):761. PubMed ID: 21738140
    [No Abstract]   [Full Text] [Related]  

  • 16. No money, no meds.
    Mabry M
    Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648
    [No Abstract]   [Full Text] [Related]  

  • 17. Pfizer swallows Wyeth, validates niche buster.
    Sheridan C
    Nat Biotechnol; 2009 Mar; 27(3):218-9. PubMed ID: 19270661
    [No Abstract]   [Full Text] [Related]  

  • 18. Proteomics. Gene and protein patents get ready to go head to head.
    Service RF
    Science; 2001 Dec; 294(5549):2082-3. PubMed ID: 11739934
    [No Abstract]   [Full Text] [Related]  

  • 19. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 20. Essential AIDS medications in India.
    Thomas J
    Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.